Generalization and safety of the second-line levofloxacin or Bismuth-based quadruple therapy for Helicobacter eradication

被引：0
|
作者：
Hu, Bowen [1 ]
Huanfei, Ding [1 ,2 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, 1 Eastern Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 11期
关键词：
D O I：
10.1016/j.asjsur.2023.06.082
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5079 / 5079
页数：1
相关论文
共 50 条
  • [11] SECOND-LINE RESCUE THERAPY WITH LEVOFLOXACIN AND BISMUTH AFTER FAILURE OF A HELICOBACTER PYLORI ERADICATION TREATMENT
    Gisbert, J. P.
    Solis-Munoz, P.
    Romano, M.
    Gravina, A.
    Lucendo, A.
    Molina-Infante, J.
    Velayos, B.
    Herranz, M.
    Barrio, J.
    Modolell, I.
    Gomez, J.
    Del Castillo, F.
    Dominguez, J. L.
    Federico, A.
    Martorano, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Miranda, A.
    Marin, A. C.
    McNicholl, A. G.
    [J]. HELICOBACTER, 2014, 19 : 135 - 135
  • [12] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Kim, Jae Hyun
    Jung, Kyoungwon
    Kim, Hae Koo
    Dal Lee, Young
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1059 - 1066
  • [13] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    [J]. World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [14] Levofloxacin-based triple therapy versus bismuth-based quadruple therapy as a second line treatment for the eradication of H. pylori infection
    Karatapanis, S.
    Skorda, L.
    Georgopoulos, S.
    Papantoniou, N.
    Papastergiou, V.
    Ntoutsikos, K.
    Komnianides, K.
    Lisgos, Ph
    [J]. ANNALS OF GASTROENTEROLOGY, 2009, 22 (04): : 263 - 267
  • [15] Levofloxacin, Bismuth, Amoxicillin and Esomeprazole As Second-Line Helicobacter pylori Therapy After Failure of Non-Bismuth Quadruple Therapy
    Song, Zhiqiang
    Zhou, Liya
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S879 - S879
  • [16] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
    Lee, M.
    Lee, B.
    Kim, G.
    Park, E.
    Jeon, H.
    Song, G.
    [J]. HELICOBACTER, 2017, 22
  • [17] Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (05) : 506 - 511
  • [18] Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
    Seyyedmajidi, Mohamadreza
    Abbasi, Laleh
    Seyedmajidi, Seyedali
    Hosseini, Seyed Ashkan
    Ahmadi, Anahita
    Hajiebrahimi, Shahin
    Vafaeimanesh, Jamshid
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (02) : 211 - 216
  • [19] Levofloxacin/Amoxicillin-Based Regimens Versus Quadruple Therapy for Helicobacter pylori Eradication in Second-Line: A Meta-Analysis
    Di Caro, Simona
    Fini, Lucia
    Daoud, Yayha
    Laghi, Luigi
    Gasbarrini, Antonio
    McCartney, Sara
    Bloom, Stuart L.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S879 - S879
  • [20] Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
    Liou, Jyh-Ming
    Jiang, Xiao-Tao
    Chen, Chieh-Chang
    Luo, Jiing-Chyuan
    Bair, Ming-Jong
    Chen, Po-Yueh
    Chou, Chu-Kuang
    Fang, Yu-Jen
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Lee, Ji-Yuh
    Yang, Tsung-Hua
    Yu, Chien-Chun
    Kuo, Chia-Chi
    Chiu, Min-Chin
    Chen, Chi-Yi
    Shun, Chia-Tung
    Hu, Wen-Hao
    Tsai, Min-Horn
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Chang, Chi-Yang
    Lin, Jaw-Town
    El-Omar, Emad M.
    Wu, Ming-Shiang
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 228 - 241
12345